Bristol-Myers Squibb Company (BMY) · page 30 of 197
This is a classic activist investor 'thesis' slide, focusing on valuation gaps and management incompetence.
Activist deck · key_takeaways · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 9/10
callout 1/2 list 5/5 paragraph 1/1 source-note 1/1 title 1/1
1 without position callout 1
callout
Components 10
primary callout bullet bullet bullet bullet bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.